Unternehmenscenter: Aktieninfos

Das AnlagerPlus-Unternehmenscenter bietet Anlegern umfassende Informationen zu Aktien und Aktiengesellschaften. Hier finden Sie aktuelle Unternehmensnachrichten, einschließlich News und Ad-Hoc-Mitteilungen, sowie Geschäftsberichte und Quartalsberichte. Darüber hinaus erhalten Sie wichtige Informationen zu Unternehmensterminen, Jahreszahlen und Quartalsergebnisse sowie die Kontaktdaten der Investor Relations-Abteilungen deutscher börsennotierter Aktien bzw. Aktiengesellschaften

Die Daten werden übermittelt von der EQS Group AG. Eine Speicherung in Datenbanken sowie jegliche Weiterleitung der Nachrichten an Dritte im Rahmen gewerblicher Nutzung oder zur gewerblichen Nutzung sind nur nach schriftlicher Genehmigung durch die EQS Group AG gestattet.

Corestate Capital Holding S.A.

Management

Es wurden keine Daten übermittelt.

IR-Kontakt

Es wurden keine Daten übermittelt.

Stammdaten

Es wurden keine Daten übermittelt.

Aktionärsstruktur

Es wurden keine Daten übermittelt.

    Profil

Corestate ist ein Investment und Asset Manager mit einem verwalteten Vermögen im Kerngeschäft von ca. 12 Milliarden Euro (31.12.2023). Das Unternehmen bietet Investoren über seine Immobilien-Plattform die Möglichkeit, in große gesellschaftliche Trends wie Urbanisierung, demografischer Wandel oder Nachhaltigkeit zu investieren, welche die Wohn-, Lebens- und Arbeitswelt langfristig weiter entscheidend beeinflussen werden. Die konsequente Fokussierung auf nachhaltig erfolgreiche Assetklassen ist ein zentraler Eckpunkt der Unternehmensstrategie. Mit über 100 Expertinnen und Experten hält Corestate für Kunden und Investoren ein breites Service- & Beratungsspektrum aus einer Hand bereit – von der Akquisition über das Management von Immobilien bis zum Verkauf. Corestate ist an der Frankfurter Wertpapierbörse notiert und mit Niederlassungen in Luxemburg, Frankfurt, München und Paris als Geschäftspartner für institutionelle und semi-institutionelle Investoren sowie vermögende Privatanleger tätig. Weitere Informationen finden Sie unter: www.corestate-capital.com.

Geschäftsberichte

Keine Dokumente gefunden.

Quartalszahlen

Keine Dokumente gefunden.

Sonstige Dokumente

Keine Dokumente gefunden.
DatumUnternehmensmeldung
05.03.2026CORESTATE CAPITAL HOLDING S.A.: Bekanntmachung der Einberufung zur Hauptversammlung am 25.03.2026 in Luxemburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
Logo

CORESTATE CAPITAL HOLDING S.A. / Bekanntmachung der Einberufung zur Hauptversammlung
CORESTATE CAPITAL HOLDING S.A.: Bekanntmachung der Einberufung zur Hauptversammlung am 25.03.2026 in Luxemburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

05.03.2026 / 15:05 CET/CEST
Bekanntmachung gemäß §121 AktG, übermittelt durch EQS News
- ein Service der EQS Group.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

CORESTATE CAPITAL HOLDING S.A. 9, Grand-Rue, L-1661 Luxembourg, Grand Duchy of Luxembourg Registered with the Luxembourg Trade and Companies Register under registration number B 199780 (the Company) REVISED AGENDA FOR THE ANNUAL GENERAL MEETING OF CORESTATE CAPITAL HOLDING S.A.


On 27 February 2026, Nut Tree Capital Management L.P., as investment advisor for and on behalf of Nut Tree Master Fund, L.P. (the Proposing Shareholder) being shareholder representing more than 5% of the Company’s share capital, in accordance with article 4(1) of the Luxembourg law dated 24 May 2011 relating to the exercise of certain rights of shareholders at general meetings of listed companies, as amended (the 2011 Law),

requested that the Company add a new item (31) to the agenda of the annual general meeting of the shareholders of the Company (the Meeting), which shall be held

on 25 March 2026
at 10:00 a.m. CET
at Novotel Luxembourg Kirchberg, Quartier Européen Nord, 6, rue Fort Niedergrünewald, L-2226 Luxembourg, Grand Duchy of Luxembourg

and which was convened pursuant to a convening notice dated 24 February 2026.

Consequently, the Company hereby publishes, on the Company’s website, the Recueil Electronique des Sociétés et Associations, the Luxemburger Wort and the German Bundesanzeiger, the revised agenda for the Meeting, including the new item 31, in accordance with article 4 (4) of the 2011 Law:

REVISED AGENDA FOR THE MEETING
 
01

APPOINTMENT OF THE INDEPENDENT AUDITOR (CABINET DE RÉVISION AGRÉÉ) FOR THE FINANCIAL YEARS 2022 TO 2026
The CEO and the supervisory board of the Company (the Supervisory Board) propose that the Meeting approves the appointment of KPMG Audit S.à r.l., with registered office at 39, John F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg (KPMG), as independent auditor (cabinet de révision agréé) for the stand-alone annual accounts and consolidated financial statements of the Company for the financial years 2022 to 2026 (inclusive).
02

PRESENTATION AND APPROVAL OF THE STAND-ALONE ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR 2022, OF THE APPROVED CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2022, THE AUDITOR REPORT RELATING TO THE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2022 AS WELL AS THE MANAGEMENT REPORT FOR THE FINANCIAL YEAR 2022
The Supervisory Board has not made any comments on the stand-alone annual accounts, the consolidated financial statements for the financial year 2022 as drawn up by the CEO (the 2022 Financial Statements), or on the report prepared by the CEO (the 2022 Management Report) and the report of the independent auditor relating to the 2022 Financial Statements (the 2022 Auditor Report).

The CEO and the Supervisory Board propose that the Meeting approves the 2022 Financial Statements in accordance with article 461-7 of the Luxembourg act on commercial companies dated 10 August 1915, as amended (the Companies Act).
03

ACKNOWLEDGEMENT OF THE LOSS OF THE COMPANY MADE WITH RESPECT TO THE FINANCIAL YEAR 2022
The CEO proposes that the Meeting acknowledges that the Company made a loss with respect to the financial year 2022 in an aggregate amount of EUR 867,089,349.07 (the 2022 Loss).

The CEO notes that as a result of the 2022 Loss, the net assets of the Company continue to stand below one quarter of the Company’s share capital. The CEO notes that the Company’s shareholders had, at the occasion of an extraordinary general meeting of the Company held on 14 July 2023, approved the continuation of the activities of the Company despite the losses of the Company, in accordance with article 480-2 of the Companies Act.

The CEO proposes that the Meeting resolves to (i) set off the 2022 Loss against the profits and reserves carried forward from the previous financial year and (ii) carry forward the balance of losses in an aggregate amount of EUR 768,412,207.82 to the next financial year.
04

DISCHARGE (QUITUS) TO MR UDO GIEGERICH FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Udo Giegerich for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2022.
05

DISCHARGE (QUITUS) TO MRS IZABELA DANNER FOR THE PERFORMANCE OF HER MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mrs Izabela Danner for the performance of her duties as member of the Management Board for, and in connection with, the financial year 2022.
06

DISCHARGE (QUITUS) TO MR RALF STRUCKMEYER FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Ralf Struckmeyer for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2022.
07

DISCHARGE (QUITUS) TO MR STAVROS EFREMIDIS FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Stavros Efremidis for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2022.
08

DISCHARGE (QUITUS) TO MR STAVROS EFREMIDIS FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Stavros Efremidis for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
09

DISCHARGE (QUITUS) TO DR. FRIEDRICH OELRICH FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Friedrich Oelrich for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
10

DISCHARGE (QUITUS) TO DR. BERTRAND MALMENDIER FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Bertrand Malmendier for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
11

DISCHARGE (QUITUS) TO DR. ROLAND MANFRED FOLZ FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Roland Manfred Folz for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
12

DISCHARGE (QUITUS) TO DR. NEDIM CEN FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Nedim Cen for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
13

DISCHARGE (QUITUS) TO DR. SVEN-MARIAN BERNEBURG FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Sven-Marian Berneburg for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
14

ADVISORY NON-BINDING VOTE ON THE REMUNERATION REPORT FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting approves, on a non-binding basis, the remuneration report for the financial year 2022 (the 2022 Remuneration Report) in accordance with the requirements of article 7ter of the Luxembourg law dated 24 May 2011 relating to the exercise of certain rights of shareholders at general meetings of listed companies, as amended (the 2011 Law).
15

ADVISORY NON-BINDING VOTE ON THE UPDATED REMUNERATION POLICY
The CEO and the Supervisory Board propose that the Meeting approves, on a non-binding basis, the updated remuneration policy (the Remuneration Policy) in accordance with the requirements of article 7bis of the 2011 Law.
16

APPROVAL OF THE PARTICIPATION OF DR. SVEN-MARIAN BERNEBURG IN THE LONG-TERM INCENTIVE PLAN
The CEO and the Supervisory Board propose that the Meeting approves that Dr. Sven-Marian Berneburg may participate in the long-term incentive plan of the Company as set out in the Remuneration Policy and receive a number of 1,661,595 ordinary shares in the Company under such long-term incentive plan.
17

PRESENTATION AND APPROVAL OF THE STAND-ALONE ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR 2023, OF THE APPROVED CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2023, THE AUDITOR REPORT RELATING TO THE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2023 AS WELL AS THE MANAGEMENT REPORT FOR THE FINANCIAL YEAR 2023
The Supervisory Board has not made any comments on the stand-alone annual accounts, the consolidated financial statements for the financial year 2023 as drawn up by the CEO (the 2023 Financial Statements and, together with the 2022 Financial Statements, the Financial Statements), or on the report prepared by the CEO (the 2023 Management Report and, together with the 2022 Management Report, the Management Reports) and the report of the independent auditor relating to the 2023 Financial Statements (the 2023 Auditor Report and, together with the 2022 Auditor Report, the Auditor Reports).

The CEO and the Supervisory Board propose that the Meeting approves the 2023 Financial Statements in accordance with article 461-7 of the Companies Act.
18

ACKNOWLEDGEMENT OF THE PROFIT OF THE COMPANY MADE WITH RESPECT TO THE FINANCIAL YEAR 2023
The CEO proposes that the Meeting acknowledges that the Company made a profit with respect to the financial year 2023 in an aggregate amount of EUR 287,971,692.26 (the 2023 Profit).

The CEO notes that despite the 2023 Profit, the net assets of the Company continue to stand below one quarter of the Company’s share capital. The CEO notes that the Company’s shareholders had, at the occasion of an extraordinary general meeting of the Company held on 14 July 2023, approved the continuation of the activities of the Company despite the losses of the Company, in accordance with article 480-2 of the Companies Act.

The CEO proposes that the Meeting resolves to (i) set off the 2023 Profit against the losses carried forward from the previous financial year and (ii) carry forward the balance of losses in an aggregate amount of EUR 480,440,515.56 to the next financial year.
19

DISCHARGE (QUITUS) TO MR UDO GIEGERICH FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Udo Giegerich for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2023.
20

DISCHARGE (QUITUS) TO MRS IZABELA DANNER FOR THE PERFORMANCE OF HER MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mrs Izabela Danner for the performance of her duties as member of the Management Board for, and in connection with, the financial year 2023.
21

DISCHARGE (QUITUS) TO MR STEPHAN GÖTSCHEL FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Stephan Götschel for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2023.
22

DISCHARGE (QUITUS) TO DR. NEDIM CEN FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Nedim Cen for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2023.
23

DISCHARGE (QUITUS) TO DR. NEDIM CEN FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Nedim Cen for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2023.
24

DISCHARGE (QUITUS) TO DR. BERTRAND MALMENDIER FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Bertrand Malmendier for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2023.
25

DISCHARGE (QUITUS) TO DR. SVEN-MARIAN BERNEBURG FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Sven-Marian Berneburg for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2023.
26

DISCHARGE (QUITUS) TO DR. CARLOS MACK FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Carlos Mack for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2023.
27

CONFIRMATION AND APPOINTMENT OF MR ANDREAS PAUL UELHOFF AS MEMBER OF THE SUPERVISORY BOARD
The CEO and the Supervisory Board propose that the Meeting (i) confirms the appointment by co-optation of Mr Andreas Paul Uelhoff as member of the Supervisory Board, with effect as of 1 January 2025 and (ii) appoints Mr Andreas Paul Uelhoff as member of the Supervisory Board, for a term of office ending after the annual general meeting of the Company approving the annual accounts of the Company of the financial year ending on 31 December 2027.

Further information about the proposed candidate is available on the Company’s website at www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting” and will be available for inspection during the Meeting.
28

CONFIRMATION AND APPOINTMENT OF MR WOLFGANG BAUER AS MEMBER OF THE SUPERVISORY BOARD
The CEO and the Supervisory Board propose that the Meeting (i) confirms the appointment by co-optation of Mr Wolfgang Bauer as member of the Supervisory Board, with effect as of 1 January 2025 and (ii) appoints Mr Wolfgang Bauer as member of the Supervisory Board for a term of office ending after the annual general meeting of the Company approving the annual accounts of the Company of the financial year ending on 31 December 2027.

Further information about the proposed candidate is available on the Company’s website at www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting” and will be available for inspection during the Meeting.
29

APPOINTMENT OF DR. SVEN-MARIAN BERNEBURG AS MEMBER OF THE SUPERVISORY BOARD
The CEO and the Supervisory Board propose that the Meeting appoints Dr. Sven-Marian Berneburg as member of the Supervisory Board for a term of office ending after the annual general meeting of the Company approving the annual accounts of the Company of the financial year ending on 31 December 2029.
30

ADVISORY NON-BINDING VOTE ON THE REMUNERATION REPORT FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting approves, on a non-binding basis, the remuneration report for the financial year 2023 (the 2023 Remuneration Report and, together with the 2022 Remuneration Report, the Remuneration Reports) in accordance with the requirements of article 7ter of the 2011 Law.
31

APPROVAL OF A ONE-OFF CASH BONUS PAYMENT TO DR. SVEN-MARIAN BERNEBURG FOR THE FINANCIAL YEAR 2023
The Proposing Shareholder proposes that the Meeting approves the payment of a one-off cash bonus in a gross amount of EUR 200,000.00 to Dr. Sven-Marian Berneburg, in his capacity as a member of the Supervisory Board in recognition of his significant contributions to the Company’s restructuring efforts during the financial year 2023. In addition to the documented regular and ad hoc meetings of the Supervisory Board in 2023, Dr. Berneburg, in his capacity as member of the Supervisory Board and later in his role as Chairman of the Supervisory Board, played a key role in helping the Corestate Management Board to develop and implement the restructuring concept and put it into practice. In particular with regard to the alternative restructuring concept published in April 2023, Dr. Berneburg contributed significant efforts in ensuring that a practicable restructuring concept could be developed through his regular participation in conference calls with the Company, the appointed advisors and investors as well as other relevant stakeholders. Considering that no annual general meeting has been scheduled since then, the approval of this exceptional bonus payment could not be proposed earlier.

This revised agenda replaces the initial agenda set out in the convening notice dated 24 February 2026 and shall be read in conjunction with all other information set out in such convening notice.

Revised proxy and correspondence voting forms are made available on the Company’s website under www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting” and at the Company’s registered office in Luxembourg, as of the day of the publication of this revised convening notice and are available at:

Corestate Capital Holding S.A.
c/o GFEI HV GmbH
Ostergrube 11
30559 Hannover
Germany
Fax: +49 511 47402319
E-Mail: HV@gfei.de

 

Luxembourg, 5 March 2026.

Corestate Capital Holding S.A., Société Anonyme

The CEO


05.03.2026 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Sprache: Deutsch
Unternehmen: CORESTATE CAPITAL HOLDING S.A.
9-11, Grand-Rue
1661 Luxembourg
Luxemburg
E-Mail: patrick.ehrich@corestate-capital.com
Internet: https://www.corestate-capital.com
ISIN: LU1296758029

 
Ende der Mitteilung EQS News-Service

2286584  05.03.2026 CET/CEST

24.02.2026CORESTATE CAPITAL HOLDING S.A.: Bekanntmachung der Einberufung zur Hauptversammlung am 25.03.2026 in Luxemburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
Logo

CORESTATE CAPITAL HOLDING S.A. / Bekanntmachung der Einberufung zur Hauptversammlung
CORESTATE CAPITAL HOLDING S.A.: Bekanntmachung der Einberufung zur Hauptversammlung am 25.03.2026 in Luxemburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

24.02.2026 / 15:05 CET/CEST
Bekanntmachung gemäß §121 AktG, übermittelt durch EQS News
- ein Service der EQS Group.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

CORESTATE CAPITAL HOLDING S.A. 9, Grand-Rue, L-1661 Luxembourg, Grand Duchy of Luxembourg Registered with the Luxembourg Trade and Companies Register
under registration number B 199780


Luxembourg, 24 February 2026

CONVENING NOTICE TO THE ANNUAL GENERAL MEETING OF THE SHAREHOLDERS


The chief executive officer (the CEO) and sole director of Corestate Capital Holding S.A. (the Company) hereby convenes all shareholders to the annual general meeting of the shareholders of the Company (the Meeting), which shall be held

on 25 March 2026
at 10:00 a.m. CET
at Novotel Luxembourg Kirchberg, Quartier Européen Nord, 6, rue Fort Niedergrünewald, L-2226 Luxembourg, Grand Duchy of Luxembourg

with the agenda set out below.

I.

Quorum and majority requirements
Pursuant to the Company’s articles of association (the Articles) and applicable law, resolutions at the Meeting are adopted by a simple majority of the votes validly cast, regardless of the portion of capital represented.
II.

Agenda

01

APPOINTMENT OF THE INDEPENDENT AUDITOR (CABINET DE RÉVISION AGRÉÉ) FOR THE FINANCIAL YEARS 2022 TO 2026
The CEO and the supervisory board of the Company (the Supervisory Board) propose that the Meeting approves the appointment of KPMG Audit S.à r.l., with registered office at 39, John F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg (KPMG), as independent auditor (cabinet de révision agréé) for the stand-alone annual accounts and consolidated financial statements of the Company for the financial years 2022 to 2026 (inclusive).
02

PRESENTATION AND APPROVAL OF THE STAND-ALONE ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR 2022, OF THE APPROVED CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2022, THE AUDITOR REPORT RELATING TO THE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2022 AS WELL AS THE MANAGEMENT REPORT FOR THE FINANCIAL YEAR 2022
The Supervisory Board has not made any comments on the stand-alone annual accounts, the consolidated financial statements for the financial year 2022 as drawn up by the CEO (the 2022 Financial Statements), or on the report prepared by the CEO (the 2022 Management Report) and the report of the independent auditor relating to the 2022 Financial Statements (the 2022 Auditor Report).

The CEO and the Supervisory Board propose that the Meeting approves the 2022 Financial Statements in accordance with article 461-7 of the Luxembourg act on commercial companies dated 10 August 1915, as amended (the Companies Act).
03

ACKNOWLEDGEMENT OF THE LOSS OF THE COMPANY MADE WITH RESPECT TO THE FINANCIAL YEAR 2022
The CEO proposes that the Meeting acknowledges that the Company made a loss with respect to the financial year 2022 in an aggregate amount of EUR 867,089,349.07 (the 2022 Loss).

The CEO notes that as a result of the 2022 Loss, the net assets of the Company continue to stand below one quarter of the Company’s share capital. The CEO notes that the Company’s shareholders had, at the occasion of an extraordinary general meeting of the Company held on 14 July 2023, approved the continuation of the activities of the Company despite the losses of the Company, in accordance with article 480-2 of the Companies Act.

The CEO proposes that the Meeting resolves to (i) set off the 2022 Loss against the profits and reserves carried forward from the previous financial year and (ii) carry forward the balance of losses in an aggregate amount of EUR 768,412,207.82 to the next financial year.
04

DISCHARGE (quitus) to Mr Udo Giegerich for the performance of his mandate as member of the management board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Udo Giegerich for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2022.
05

DISCHARGE (quitus) to Mrs Izabela Danner for the performance of her mandate as member of the management board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mrs Izabela Danner for the performance of her duties as member of the Management Board for, and in connection with, the financial year 2022.
06

DISCHARGE (quitus) to Mr Ralf Struckmeyer for the performance of his mandate as member of the management board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Ralf Struckmeyer for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2022.
07

DISCHARGE (quitus) to Mr Stavros Efremidis for the performance of his mandate as member of the Management board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Stavros Efremidis for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2022.
08

DISCHARGE (quitus) to Mr Stavros Efremidis for the performance of his mandate as member of the Supervisory Board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Stavros Efremidis for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
09

DISCHARGE (quitus) to Dr. Friedrich Oelrich for the performance of his mandate as member of the Supervisory Board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Friedrich Oelrich for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
10

DISCHARGE (quitus) to Dr. Bertrand Malmendier for the performance of his mandate as member of the Supervisory Board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Bertrand Malmendier for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
11

DISCHARGE (quitus) to Dr. Roland Manfred Folz for the performance of his mandate as member of the Supervisory Board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Roland Manfred Folz for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
12

DISCHARGE (quitus) to Dr. Nedim Cen for the performance of his mandate as member of the Supervisory Board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Nedim Cen for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
13

DISCHARGE (quitus) to Dr. Sven-Marian Berneburg for the performance of his mandate as member of the Supervisory Board for the financial year 2022
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Sven-Marian Berneburg for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2022.
14

ADVISORY NON-BINDING VOTE ON THE REMUNERATION REPORT FOR THE FINANCIAL YEAR 2022
The CEO and the Supervisory Board propose that the Meeting approves, on a non-binding basis, the remuneration report for the financial year 2022 (the 2022 Remuneration Report) in accordance with the requirements of article 7ter of the Luxembourg law dated 24 May 2011 relating to the exercise of certain rights of shareholders at general meetings of listed companies, as amended (the 2011 Law).
15

ADVISORY NON-BINDING VOTE ON THE UPDATED REMUNERATION POLICY
The CEO and the Supervisory Board propose that the Meeting approves, on a non-binding basis, the updated remuneration policy (the Remuneration Policy) in accordance with the requirements of article 7bis of the 2011 Law.
16

APPROVAL OF THE PARTICIPATION OF DR. SVEN-MARIAN BERNEBURG IN THE LONG-TERM INCENTIVE PLAN
The CEO and the Supervisory Board propose that the Meeting approves that Dr. Sven-Marian Berneburg may participate in the long-term incentive plan of the Company as set out in the Remuneration Policy and receive a number of 1,661,595 ordinary shares in the Company under such long-term incentive plan.
17

PRESENTATION AND APPROVAL OF THE STAND-ALONE ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR 2023, OF THE APPROVED CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2023, THE AUDITOR REPORT RELATING TO THE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR 2023 AS WELL AS THE MANAGEMENT REPORT FOR THE FINANCIAL YEAR 2023
The Supervisory Board has not made any comments on the stand-alone annual accounts, the consolidated financial statements for the financial year 2023 as drawn up by the CEO (the 2023 Financial Statements and, together with the 2022 Financial Statements, the Financial Statements), or on the report prepared by the CEO (the 2023 Management Report and, together with the 2022 Management Report, the Management Reports) and the report of the independent auditor relating to the 2023 Financial Statements (the 2023 Auditor Report and, together with the 2022 Auditor Report, the Auditor Reports).

The CEO and the Supervisory Board propose that the Meeting approves the 2023 Financial Statements in accordance with article 461-7 of the Companies Act.
18

ACKNOWLEDGEMENT OF THE PROFIT OF THE COMPANY MADE WITH RESPECT TO THE FINANCIAL YEAR 2023
The CEO proposes that the Meeting acknowledges that the Company made a profit with respect to the financial year 2023 in an aggregate amount of EUR 287,971,692.26 (the 2023 Profit).

The CEO notes that despite the 2023 Profit, the net assets of the Company continue to stand below one quarter of the Company’s share capital. The CEO notes that the Company’s shareholders had, at the occasion of an extraordinary general meeting of the Company held on 14 July 2023, approved the continuation of the activities of the Company despite the losses of the Company, in accordance with article 480-2 of the Companies Act.

The CEO proposes that the Meeting resolves to (i) set off the 2023 Profit against the losses carried forward from the previous financial year and (ii) carry forward the balance of losses in an aggregate amount of EUR 480,440,515.56 to the next financial year.
19

DISCHARGE (QUITUS) TO MR UDO GIEGERICH FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Udo Giegerich for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2023.
20

DISCHARGE (QUITUS) TO MRS IZABELA DANNER FOR THE PERFORMANCE OF HER MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mrs Izabela Danner for the performance of her duties as member of the Management Board for, and in connection with, the financial year 2023.
21

DISCHARGE (QUITUS) TO MR STEPHAN GÖTSCHEL FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Mr Stephan Götschel for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2023.
22

DISCHARGE (QUITUS) TO DR. NEDIM CEN FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE MANAGEMENT BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Nedim Cen for the performance of his duties as member of the Management Board for, and in connection with, the financial year 2023.
23

DISCHARGE (QUITUS) TO DR. NEDIM CEN FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Nedim Cen for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2023.
24

DISCHARGE (QUITUS) TO DR. BERTRAND MALMENDIER FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Bertrand Malmendier for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2023.
25

DISCHARGE (QUITUS) TO DR. SVEN-MARIAN BERNEBURG FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Sven-Marian Berneburg for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2023.
26

DISCHARGE (QUITUS) TO DR. CARLOS MACK FOR THE PERFORMANCE OF HIS MANDATE AS MEMBER OF THE SUPERVISORY BOARD FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting grants discharge (quitus) to Dr. Carlos Mack for the performance of his duties as member of the Supervisory Board for, and in connection with, the financial year 2023.
27

CONFIRMATION AND APPOINTMENT OF MR ANDREAS PAUL UELHOFF AS MEMBER OF THE SUPERVISORY BOARD
The CEO and the Supervisory Board propose that the Meeting (i) confirms the appointment by co-optation of Mr Andreas Paul Uelhoff as member of the Supervisory Board, with effect as of 1 January 2025 and (ii) appoints Mr Andreas Paul Uelhoff as member of the Supervisory Board, for a term of office ending after the annual general meeting of the Company approving the annual accounts of the Company of the financial year ending on 31 December 2027.

Further information about the proposed candidate is available on the Company’s website at www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting” and will be available for inspection during the Meeting.
28

CONFIRMATION AND APPOINTMENT OF MR WOLFGANG BAUER AS MEMBER OF THE SUPERVISORY BOARD
The CEO and the Supervisory Board propose that the Meeting (i) confirms the appointment by co-optation of Mr Wolfgang Bauer as member of the Supervisory Board, with effect as of 1 January 2025 and (ii) appoints Mr Wolfgang Bauer as member of the Supervisory Board for a term of office ending after the annual general meeting of the Company approving the annual accounts of the Company of the financial year ending on 31 December 2027.

Further information about the proposed candidate is available on the Company’s website at www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting” and will be available for inspection during the Meeting.
29

APPOINTMENT OF DR. SVEN-MARIAN BERNEBURG AS MEMBER OF THE SUPERVISORY BOARD
The CEO and the Supervisory Board propose that the Meeting appoints Dr. Sven-Marian Berneburg as member of the Supervisory Board for a term of office ending after the annual general meeting of the Company approving the annual accounts of the Company of the financial year ending on 31 December 2029.
30

ADVISORY NON-BINDING VOTE ON THE REMUNERATION REPORT FOR THE FINANCIAL YEAR 2023
The CEO and the Supervisory Board propose that the Meeting approves, on a non-binding basis, the remuneration report for the financial year 2023 (the 2023 Remuneration Report and, together with the 2022 Remuneration Report, the Remuneration Reports) in accordance with the requirements of article 7ter of the 2011 Law.
III.

Total number of shares
On the date of the convening of the Meeting, the Company’s subscribed share capital equals EUR 30,000, represented by 166,159,451 shares without nominal value, all of which are fully paid up. Each share carries one vote, it being noted that the 16,390,892 shares currently held by Corestate Capital Advisors GmbH are considered as treasury shares and the voting rights attached to such shares are therefore suspended. The total number of voting rights is therefore 149,768,559.
IV.

Available information and documentation
The following information is available on the Company’s website under www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting” and at the Company’s registered office in Luxembourg, as of the day of the publication of this convening notice:

(i)

full text of any document to be made available by the Company at the Meeting, including draft resolutions in relation to the above agenda items to be adopted at the Meeting and related documents (i.e. inter alia the Financial Statements, the Management Reports, the Supervisory Board reports, the Auditor Reports and the Remuneration Reports);
(ii)

this convening notice;
(iii)

the total number of shares and attached voting rights issued by the Company as of the date of publication of this convening notice;
(iv)

the proxy form as further mentioned below; and
(v)

the correspondence voting form as further mentioned below.
V.

Attendance
Each shareholder shall, on or before the Record Date (as defined below) indicate to the Company their intention to participate at the Meeting.

The participation at the Meeting and the exercise of voting rights attached to the shares held by a shareholder is determined in relation to the number of shares held by each shareholder at 11:59 p.m. (CET) on the 14th day prior to the Meeting (11 March 2026) (the Record Date). Shareholders must produce an attestation from their depository bank stating the number of shares held by the shareholder on the Record Date in order to be permitted to exercise their rights at the Meeting. Attestations must be received by the Company (by fax or e-mail) on 19 March 2026 at 11:59 p.m. (CET) at the latest, followed by the original by regular mail, to:

Corestate Capital Holding S.A.
c/o GFEI HV GmbH
Ostergrube 11
30559 Hannover
Germany
Fax: +49 511 47402319
E-Mail: HV@gfei.de

Attestation forms are available on the Company’s website under www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting”.
VI.

Representation
Shareholders may appoint a proxy holder in writing, who does not need to be a shareholder of the Company, to attend the Meeting on their behalf. In order for the proxy form to take effect, the Company must be provided with an attestation by the depository bank relating to the shareholder and proving their status as shareholder at the beginning of the Meeting at the latest.

The duly completed and signed proxy form (by fax or e-mail) must be received by the Company on 19 March 2026 at 11:59 p.m. (CET) at the latest, followed by the original by regular mail to the address mentioned under item V. (Attendance) above.

Exercise of voting rights of shares in connection with proxy forms received after such date will not be possible.

Proxy forms are available on the Company’s website under www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting”.
VII.

Vote by correspondence
Shareholders may also vote by correspondence. Please note that such form must be fully completed, signed and sent back to the Company in two originals. Voting forms which do not specify how a vote shall be counted or if the vote is retained, are void (nul). Voting forms must in any event include an attestation from the depository bank stating the number of shares held by the shareholder on the Record Date (see V. Attendance) as attachment.

The duly completed and signed voting forms (by fax or e-mail) must be received by the Company on 19 March 2026 at 11:59 p.m. (CET) at the latest, followed by the original by regular mail to the address mentioned under item V. (Attendance) above.

Exercise of voting rights of shares in connection with voting forms received after such date will not be possible.

Voting forms are available on the Company’s website under www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting”.
VIII.

Additional important information for shareholders
Shareholders are hereby informed that the exercise of voting rights is exclusively reserved to such persons that were shareholders on the Record Date (or their duly appointed proxyholders). Transfer of shares after the Record Date is possible subject to usual transfer limitations, as applicable. However, any transferee having become owner of shares after the Record Date has no right to vote at the Meeting.

One or more shareholder(s) representing at least 5% of the Company’s share capital may request the addition of items to the agenda of the Meeting or table draft resolutions for items included or to be included on the agenda of the Meeting by sending such requests (by fax, post or e-mail) at the latest on 3 March 2026 at 11:59 p.m. (CET) to the contact information mentioned under item V. (Attendance) above.

Such request will only be accepted by the Company provided it includes (i) the wording of the agenda point, (ii) the wording of a proposed resolution pertaining to such agenda point or a justification, and (iii) an e-mail address and a postal address to which the Company may correspond and confirm receipt of the request.

If you have questions regarding the Meeting feel free to call our meeting hotline +49 511 47402310 or send us an e-mail at hv@gfei.de (meeting hotline available from 9 a.m. to 5 p.m. CET except on bank holidays in Luxembourg or Germany).
IX.

Data Protection Notice
Since the European Data Protection Act came into effect, data protection laws and regulations apply throughout Europe from 25 May 2018 onwards.

The protection of your data and the legally compliant processing of your data have a high priority for us. In our data protection notice for shareholders, we have summarized all information regarding the processing of personal data of our shareholders in a clear and structured way.

The data protection notice for shareholders can be retrieved and is available for viewing and downloading on the Company's website under www.corestate-capital.com in the segment “Investor Relations” > “Corporate Governance & General Meeting” > “General Meeting”.

The direct link is:
https://corestate-capital.com/wp-content/uploads/2026/02/20260219_Data-Protection-AGM-2026.pdf
X.

Language
Please note that the Meeting will be held in German language.

 

Luxembourg, 24 February 2026


Corestate Capital Holding S.A., Société Anonyme

The CEO


24.02.2026 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Sprache: Deutsch
Unternehmen: CORESTATE CAPITAL HOLDING S.A.
9-11, Grand-Rue
1661 Luxembourg-Ville
Luxemburg
E-Mail: info@corestate-capital.com
Internet: https://www.corestate-capital.com
ISIN: LU1296758029
WKN: A141J3
Börsen: Düsseldorf, Frankfurt, Hamburg, Hannover, München, Stuttgart, Xetra

 
Ende der Mitteilung EQS News-Service

2280876  24.02.2026 CET/CEST

26.11.2025Corestate Capital Holding S.A.: Abschluss von Lock-up Vereinbarung mit Gruppe von Anleihegläubigern
Logo

Corestate Capital Holding S.A. / Schlagwort(e): Anleihe
Corestate Capital Holding S.A.: Abschluss von Lock-up Vereinbarung mit Gruppe von Anleihegläubigern

26.11.2025 / 08:03 CET/CEST
Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Veröffentlichung von Insiderinformationen nach Artikel 17 der Verordnung (EU) Nr. 596/2014

 

Corestate Capital Holding S.A. / Schlagwort(e): Abschluss Lock-up Vereinbarung, Gläubigerversammlungen

 

Corestate Capital Holding S.A.: Abschluss von Lock-up Vereinbarung mit Gruppe von Anleihegläubigern

Luxemburg, 26. November 2025 – Die Corestate Capital Holding S.A. („Corestate“) hat heute mit einem maßgeblichen Teil der Inhaber der von der Corestate begebenen EUR 64.816.710,00 8,00% Schuldverschreibung (ISIN DE000A19YDA9) und der EUR 40.683.288,31 8,00% Schuldverschreibung (ISIN DE000A19SPK4), jeweils mit Fälligkeit am 31. Dezember 2026 (zusammen die „Schuldverschreibungen“), eine Lock-up Vereinbarung abgeschlossen. Auf dieser Basis soll die Laufzeit der Schuldverschreibungen um jeweils zwei Jahre bis zum 31. Dezember 2028 verlängert werden. Neben bestimmten weiteren Anpassungen der Bedingungen der Schuldverschreibungen ist zudem beabsichtigt die Zinssätze beider Schuldverschreibungen auf 12% ab dem Jahr 2027 sowie 15% ab dem Jahr 2028 zu erhöhen.

Die Anpassung der Bedingungen der Schuldverschreibungen soll die Rückzahlung der Schuldverschreibungen zusätzlich absichern und steht insbesondere noch unter dem Vorbehalt der Zustimmung noch einzuberufender Gläubigerversammlungen für die Schuldverschreibungen.

Mitteilende Person:

Jorg Keller, Rosenberg Strategic Communications GmbH & Co. KG, Dienstleister Investor Relations T: +49 15161527741 IR@corestate-capital.com.

 

 



Ende der Insiderinformation

26.11.2025 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Originalinhalt anzeigen: EQS News

Sprache: Deutsch
Unternehmen: Corestate Capital Holding S.A.
9-11 Grand Rue
1661 Luxemburg-Ville
Luxemburg
Telefon: +49 69 3535630-107
Fax: +49 69 3535630-299
E-Mail: IR@corestate-capital.com
Internet: www.corestate-capital.com
ISIN: LU1296758029
WKN: A141J3
Börsen: Regulierter Markt in Frankfurt (General Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart, Tradegate Exchange
EQS News ID: 2235914

 
Ende der Mitteilung EQS News-Service

2235914  26.11.2025 CET/CEST

10.04.2025Corestate Capital Holding S.A.: Corestate verkauft STAM Europe SAS
Logo

Corestate Capital Holding S.A. / Schlagwort(e): Verkauf
Corestate Capital Holding S.A.: Corestate verkauft STAM Europe SAS

10.04.2025 / 09:45 CET/CEST
Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Luxemburg, 10. April 2025 – Der Vorstand der Corestate Capital Holding S.A. („Corestate”) hat heute exklusive Vereinbarungen zum beabsichtigten Verkauf der STAM Europe SAS, Paris („STAM“) und deren Tochtergesellschaften – darunter den Alternativen Investment Fond Manager „STAM France Investment Managers“ – an die französische Atland-Gruppe, Paris abgeschlossen. Mit Atland hat Corestate einen idealen strategischen Partner für die weitere Entwicklung von STAM auf dem französischen Investmentmarkt gefunden. Die Transaktion steht Vorbehalt verschiedener Zustimmungen wie die der französischen Finanzmarktaufsicht (Autorité des marchés financiers) und soll spätestens im Laufe des dritten Quartals 2025 abgeschlossen werden. 

CORESTATE ist an der Frankfurter Wertpapierbörse im General Standard notiert und eine Holding-Gesellschaft, die Beteiligungen an Unternehmen im Bereich Real Asset Investment Management hält. Unsere Beteiligungen umfassen die Hannover Leasing sowie die STAM Europe.
 


Ende der Insiderinformation

10.04.2025 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter https://eqs-news.com
Sprache: Deutsch
Unternehmen: Corestate Capital Holding S.A.
4 Rue Jean Monnet
2180 Luxemburg
Luxemburg
Telefon: +49 69 3535630-107
Fax: +49 69 3535630-299
E-Mail: IR@corestate-capital.com
Internet: www.corestate-capital.com
ISIN: LU1296758029
WKN: A141J3
Börsen: Regulierter Markt in Frankfurt (General Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart, Tradegate Exchange
EQS News ID: 2114756

 
Ende der Mitteilung EQS News-Service

2114756  10.04.2025 CET/CEST

29.08.2024Bestellung von KPMG Audit S.à r.l. als Abschlussprüfer für die Geschäftsjahre 2022, 2023 und 2024
Logo

Corestate Capital Holding S.A. / Schlagwort(e): Jahresergebnis
Bestellung von KPMG Audit S.à r.l. als Abschlussprüfer für die Geschäftsjahre 2022, 2023 und 2024

29.08.2024 / 14:22 CET/CEST
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Luxemburg, 29. August 2024 – Mit Zustimmung des Aufsichtsrates hat der Vorstand der Corestate Capital Holding S.A. („Corestate“ oder „Gesellschaft“) am heutigen Tag das kommerzielle Angebot zur Mandatierung der Wirtschaftsprüfungsgesellschaft KPMG Audit S.à r.l. („KPMG“) als Abschlussprüfer für den Konzern- und Einzelabschluss der Corestate für die Geschäftsjahre 2022, 2023 sowie 2024 angenommen.

KPMG wird den Aktionären der Gesellschaft daher im Rahmen der nächsten Hauptversammlung (voraussichtlich Anfang 2025) zur Wahl vorgeschlagen. Auf dieser Hauptversammlung wird ebenso beabsichtigt, die geprüften Konzernabschlüsse für die Geschäftsjahre 2022 und 2023 zur Genehmigung vorzulegen. 

Corestate erreicht damit einen weiteren wichtigen Meilenstein bei der Umsetzung seiner Finanzrestrukturierung. Auf Basis der Jahresabschlüsse 2022, 2023 und 2024 soll ein Wertpapierprospekt erstellt werden, damit nach dessen behördlicher Genehmigung auch die im Rahmen der außerordentlichen Hauptversammlung vom 14. Juli 2023 neu geschaffenen Aktien an der Börse zum Handel zugelassen werden können.

„Mit KPMG haben wir eine renommierte Wirtschaftsprüfungsgesellschaft mit ausgewiesener Immobilienexpertise als Abschlussprüfer der Corestate finden können", so Dr. Nedim Cen, CEO der Corestate. Die Suche nach einem Abschlussprüfer gestaltete sich durch die nach wie vor angespannte Lage auf dem Immobilienmarkt sowie die fortgesetzte Restrukturierung der Corestate schwierig. Mit der Zulassung der neu geschaffenen Aktien wird die Umsetzung der erfolgreichen Finanzrestrukturierung der Corestate voraussichtlich Mitte 2025 final abgeschlossen.

Auch die strategische Neuausrichtung der Corestate mit einem Fokus auf Real Estate Asset und Investment Management durch die beiden Tochtergesellschaften Hannover Leasing und STAM France schreitet planmäßig voran. Die Corestate wird sich dabei zukünftig auf ihre Holdingfunktionen beschränken. Über den weiteren Fortgang der strategischen Neuausrichtung und der operativen Transformation wird der Vorstand im Rahmen der Regelkommunikation weiter regelmäßig informieren.

Über die Corestate Capital Holding S.A.

Corestate ist ein Investment und Asset Manager mit einem verwalteten Vermögen im Kerngeschäft von ca. 12 Milliarden Euro (31.12.2023). Das Unternehmen bietet Investoren über seine Immobilien-Plattform die Möglichkeit, in große gesellschaftliche Trends wie Urbanisierung, demografischer Wandel oder Nachhaltigkeit zu investieren, welche die Wohn-, Lebens- und Arbeitswelt langfristig weiter entscheidend beeinflussen werden. Die konsequente Fokussierung auf nachhaltig erfolgreiche Assetklassen ist ein zentraler Eckpunkt der Unternehmensstrategie. Mit über 100 Expertinnen und Experten hält Corestate für Kunden und Investoren ein breites Service- & Beratungsspektrum aus einer Hand bereit – von der Akquisition über das Management von Immobilien bis zum Verkauf. Corestate ist an der Frankfurter Wertpapierbörse notiert und mit Niederlassungen in Luxemburg, Frankfurt, München und Paris als Geschäftspartner für institutionelle und semi-institutionelle Investoren sowie vermögende Privatanleger tätig. Weitere Informationen finden Sie unter: www.corestate-capital.com.

 

Pressekontakt:

Rosenberg Strategic Communications
Dirk Schmitt
E-Mail: d.schmitt@rosenbergsc.com
T: +49 (0) 170 – 30 288 33

 


29.08.2024 CET/CEST Veröffentlichung einer Corporate News/Finanznachricht, übermittelt durch EQS News - ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter https://eqs-news.com
Sprache: Deutsch
Unternehmen: Corestate Capital Holding S.A.
4 Rue Jean Monnet
2180 Luxemburg
Luxemburg
Telefon: +49 69 3535630-107
Fax: +49 69 3535630-299
E-Mail: IR@corestate-capital.com
Internet: www.corestate-capital.com
ISIN: LU1296758029
WKN: A141J3
Börsen: Regulierter Markt in Frankfurt (General Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart, Tradegate Exchange
EQS News ID: 1977925

 
Ende der Mitteilung EQS News-Service

1977925  29.08.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1977925&application_name=news&site_id=airport_aws~~~7cc68db1-74de-43c8-af69-2ae0a97efdc3
29.08.2024Corestate Capital Holding S.A.: Bestellung von KPMG Audit S.à r.l. als Abschlussprüfer für die Geschäftsjahre 2022, 2023 und 2024
Logo

Corestate Capital Holding S.A. / Schlagwort(e): Jahresbericht
Corestate Capital Holding S.A.: Bestellung von KPMG Audit S.à r.l. als Abschlussprüfer für die Geschäftsjahre 2022, 2023 und 2024

29.08.2024 / 13:56 CET/CEST
Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News - ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Luxemburg, 29. August 2024 – Mit Zustimmung des Aufsichtsrates hat der Vorstand der Corestate Capital Holding S.A. („Corestate“ oder „Gesellschaft“) am heutigen Tag das kommerzielle Angebot zur Mandatierung der Wirtschaftsprüfungsgesellschaft KPMG Audit S.à r.l. („KPMG“) als Abschlussprüfer für den Konzern- und Einzelabschluss der Corestate für die Geschäftsjahre 2022, 2023 sowie 2024 angenommen.

KPMG wird den Aktionären der Gesellschaft daher im Rahmen der nächsten Hauptversammlung (voraussichtlich Anfang 2025) zur Wahl vorgeschlagen. Auf dieser Hauptversammlung wird ebenso beabsichtigt, die geprüften Konzernabschlüsse für die Geschäftsjahre 2022 und 2023 zur Genehmigung vorzulegen. 

 



Ende der Insiderinformation

29.08.2024 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter https://eqs-news.com
Sprache: Deutsch
Unternehmen: Corestate Capital Holding S.A.
4 Rue Jean Monnet
2180 Luxemburg
Luxemburg
Telefon: +49 69 3535630-107
Fax: +49 69 3535630-299
E-Mail: IR@corestate-capital.com
Internet: www.corestate-capital.com
ISIN: LU1296758029
WKN: A141J3
Börsen: Regulierter Markt in Frankfurt (General Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart, Tradegate Exchange
EQS News ID: 1977893

 
Ende der Mitteilung EQS News-Service

1977893  29.08.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1977893&application_name=news&site_id=airport_aws~~~7cc68db1-74de-43c8-af69-2ae0a97efdc3
16.10.2023Corestate Capital Holding S.A.: Corestate verkauft CRM Students und Upartments – Konzentration auf Kerngeschäft Asset Management
Logo

Corestate Capital Holding S.A. / Schlagwort(e): Strategische Unternehmensentscheidung/Verkauf
Corestate Capital Holding S.A.: Corestate verkauft CRM Students und Upartments – Konzentration auf Kerngeschäft Asset Management

16.10.2023 / 11:27 CET/CEST
Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News - ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Corestate verkauft CRM Students und Upartments – Konzentration auf Kerngeschäft Asset Management

Luxemburg, 16. Oktober 2023 – Der Vorstand der Corestate Capital Holding S.A. („Corestate”) hat heute beschlossen, CRM Students Ltd, Oxford („CRM“) und in der Folge die Upartments Real Estate GmbH, Leipzig („Upartments“) an die Dot Group, London zu veräußern. Die damit einhergehende Abspaltung des Property Management von Student Apartments und Serviced Apartments erfolgt im Zuge der strategischen Fokussierung der Corestate auf das Asset und Investment Management als Kerngeschäftsfeld. Die Transaktionen stehen unter den üblichen aufschiebenden Bedingungen und sollen im Laufe des vierten Quartals 2023 abgeschlossen werden. Corestate rechnet insgesamt mit einem Liquiditätszufluss von rund € 13 Millionen, darin enthalten sind auch die Rückführung von konzerninternen Finanzierungen und Positionen aus dem Umlaufvermögen. Dieser Zufluss erhöht die im Restrukturierungskonzept vorgesehenen Tilgungskapazitäten der Gruppe.

 

Mitteilende Person:

Dr. Kai Gregor Klinger 
Chief Markets Officer
T: +49 69 3535630107 /
M: +49 152 22755400 

ir@corestate-capital.com

 

 



Ende der Insiderinformation

16.10.2023 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter https://eqs-news.com
Sprache: Deutsch
Unternehmen: Corestate Capital Holding S.A.
4 Rue Jean Monnet
2180 Luxemburg
Luxemburg
Telefon: +49 69 3535630-107
Fax: +49 69 3535630-299
E-Mail: IR@corestate-capital.com
Internet: www.corestate-capital.com
ISIN: LU1296758029
WKN: A141J3
Börsen: Regulierter Markt in Frankfurt (General Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart, Tradegate Exchange
EQS News ID: 1749637

 
Ende der Mitteilung EQS News-Service

1749637  16.10.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1749637&application_name=news&site_id=airport_aws
04.10.2023HANNOVER LEASING verkauft Bildungscampus „Haus des Lebenslangen Lernens“ im hessischen Dreieich an Montano Real Estate
Logo


EQS-Media / 04.10.2023 / 07:25 CET/CEST

HANNOVER LEASING verkauft Bildungscampus „Haus des Lebenslangen Lernens“ im hessischen Dreieich an Montano Real Estate

  • Sehr gute Performance über die Laufzeit für Anleger
  • Richtungsweisendes und nachhaltiges Nutzungskonzept öffentlicher Bildung als Erfolgsrezept
  • Kaufpreis von ca. 116 Mio. Euro - einer der größten Einzeltransaktion auf dem deutschen Gewerbeimmobilienmarkt im Jahr 2023
     

München, 4. Oktober 2023 – Hannover Leasing, eine Tochter der Corestate Capital Group (Corestate), hat das Haus des Lebenslangen Lernens, Dreieich („HLL“) für einen von ihr verwalteten geschlossenen Publikumsfonds trotz herausfordernden Marktumfelds erfolgreich verkauft. Käufer ist der Investment und Asset Manager Montano Real Estate.

 Innovatives und richtungsweisendes Bildungskonzept

Mit dem vielbeachteten Bildungsprojekt Haus des Lebenslangen Lernens, Campus Dreieich hatte der Kreis Offenbach gemeinsam mit der OFB-Projektentwicklung als Projektentwickler und Hannover Leasing als Finanzierungspartner das Bildungskonzept des Europäischen Rates und die „Strategie für Lebenslanges Lernen“ von Bund und Ländern umgesetzt. Das ab 2007 zum Teil sanierte oder umgebaute und zum Teil neu errichtete Bildungszentrum in Dreieich-Sprendlingen ist inzwischen ein wichtiger Baustein der öffentlichen sozialen Infrastruktur. Es führt verschiedene Schul-, Bildungs- und Betreuungsformen des Kreises Offenbach in einem Campus für generationenübergreifendes Lernen zusammen. Auf dem HLL-Gelände lernen Kinder neben Berufsanfängern, Profis, Volkshochschülern, Studenten und Rentnern.

Der Bildungscampus wurde im Jahr 2008 mit einer Gesamtfläche von ca. 32.500 Quadratmetern sowie einem eigenen Parkhaus fertiggestellt. Das HLL ist bis zum Jahr 2038 vollständig an den Kreis Offenbach vermietet.

Hohe Transaktionssicherheit dank Gleitpreisklausel

Um der volatilen Zinsentwicklung bis zum geplanten Closing Ende September Rechnung zu tragen, war in den Kaufvertrag eine Preisgleitklausel integriert worden. Bei weiter steigendem Marktzins sollte der Kaufpreis sinken, bei fallenden Zinsen dagegen steigen. Dieser Mechanismus gab beiden Seiten Transaktionssicherheit. Mit einem Kaufpreis von rund 116 Mio. Euro ist der Verkauf eine der größten Einzeltransaktionen auf dem deutschen Gewerbeimmobilienmarkt im Jahr 2023.

Martin Eberhardt, Geschäftsführer der Hannover Leasing Investment: „Der HLL-Campus war schon 2007 ein innovatives Leuchtturmprojekt im Bereich Bildung und seiner Zeit damit weit voraus. Die Notwendigkeit von Investitionen in öffentliche Bildungsinfrastruktur bestehen nach wie vor in hohem Maße. Ein Kompliment geht an unser Asset Management, das in einem sehr herausfordernden Marktumfeld diese komplexe Transaktion erfolgreich realisiert hat. Wir haben mit diesem nachhaltigen Investment in öffentliche Infrastruktur für unsere Anleger über die Laufzeit des Fonds einen Gesamtrückfluss von über 320 Prozent bezogen auf das Eigenkapital (vor Steuern) erzielt. Das zeigt, dass wir aus einer Hand genau das bieten, was nötig ist, um anspruchsvolle Investments über den gesamten Zyklus vom Bau über das Management bis hin zum Verkauf zu begleiten.“

Der Verkäufer wurde im Rahmen des Transaktionsprozesses von der „von Kreisler & Cie. GmbH“, Pullach sowie rechtlich und steuerlich von „SATELL“, München beraten.

 

Presse- und Investor-Relations-Kontakt
Dr. Kai G. Klinger
T: +49 69 3535630-107 / M: +49 1520 22455400
ir@corestate-capital.com
 

Über HANNOVER LEASING
Die Hannover Leasing-Gruppe ist ein Real Asset Investment Manager mit über 40 Jahren Erfahrung. Insgesamt haben mehr als 70.000 private und institutionelle Investoren rund 11 Milliarden Euro Eigenkapital in unsere Produkte investiert. Für ihre Investoren entwickelt sie innovative und nachhaltige Investment-Lösungen und kombiniert dabei ihre langjährige Anlagekompetenz, gute Marktkenntnisse und die Berücksichtigung von Mega-Trends und ESG-Prinzipien. Die Investitionsschwerpunkte liegen auf Immobilien im In- und Ausland und hier insbesondere auf den Assetklassen Büro-, Wohn- und Hotelimmobilien. Zur Optimierung der Kapitalanlagen verfolgt sie in der Regel einen „Buy-Manage-Sell-Ansatz“. Dabei verfügt die Hannover Leasing Gruppe über erfahrene Experten, die den gesamten Lebenszyklus einer Immobilie professionell begleiten. Gegenwärtig betreut die Hannover Leasing Vermögenswerte in Höhe von rund 5,8 Milliarden Euro, davon rund 1,9 Milliarden Euro über ihre eigene Kapitalverwaltungsgesellschaft (AIFM), die Hannover Leasing Investment GmbH.

Über Montano Real Estate
Montano ist der hochspezialisierte, gleichgesinnte Partner für Commercial Real Estate. Wir handeln konsequent unternehmerisch und machen Komplexes einfach. Von Büros in München, Frankfurt und Berlin aus sondieren wir den Markt. Chancen erkennen wir schnell und nutzen sie beherzt. Seit über 10 Jahren entwickeln wir Investmentprodukte für deutsche und internationale institutionelle Anleger und verfolgen dabei konsequent die Ziele Nachhaltigkeit, Rendite- und Wertsteigerung. www.montano.eu

Zukunftsgerichtete Aussagen
Diese Pressemitteilung kann bestimmte in die Zukunft gerichtete Aussagen enthalten, die auf den gegenwärtigen Annahmen und Prognosen unserer Unternehmensleitung beruhen. Verschiedene bekannte wie auch unbekannte Risiken, Ungewissheiten und andere Faktoren können dazu führen, dass die tatsächlichen Ergebnisse, die Finanzlage, die Entwicklung oder die Performance unserer Gesellschaft wesentlich von den hier gegebenen Einschätzungen abweichen. Diese Faktoren schließen diejenigen ein, die wir in veröffentlichten Berichten beschrieben haben. Diese Berichte stehen auf unserer Webseite zur Verfügung. Die Gesellschaft übernimmt keinerlei Verpflichtung, solche zukunftsgerichteten Aussagen fortzuschreiben und an zukünftige Ereignisse oder Entwicklungen anzupassen. Zukunftsgerichteten Aussagen, deren Wirkung lediglich auf das Datum dieser Mitteilung abstellt, sollten keine unangemessene Bedeutung beigemessen werden.



Ende der Pressemitteilung

Emittent/Herausgeber: Corestate Capital Holding S.A.
Schlagwort(e): Immobilien

04.10.2023 CET/CEST Veröffentlichung einer Pressemitteilung, übermittelt durch EQS News - ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter https://eqs-news.com
Sprache: Deutsch
Unternehmen: Corestate Capital Holding S.A.
4 Rue Jean Monnet
2180 Luxemburg
Luxemburg
Telefon: +49 69 3535630-107
Fax: +49 69 3535630-299
E-Mail: IR@corestate-capital.com
Internet: www.corestate-capital.com
ISIN: LU1296758029
WKN: A141J3
Börsen: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart, Tradegate Exchange
EQS News ID: 1740469

 
Ende der Mitteilung EQS-Media

1740469  04.10.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1740469&application_name=news&site_id=airport_aws
Keine Events gefunden.